March 2024

Cancer Survivor’s Note: “10 Years of ‘Friendship’ with Cancer (with ECCT)”

Leave a Comment / Breast Cancer /

In 2011, Ms. Libriana was diagnosed with one of the most aggressive, treatment-resistant types of breast cancer. Refusing to give up, she searched beyond surgery, chemotherapy, and radiation until discovering ECCT therapy by Warsito P. Taruno in Tangerang—a choice that gave her new hope.

Beginning ECCT in mid-2012, she wore the electric-field vest faithfully for hours each day while continuing her normal routines. Gradually, the cancer stopped spreading, then shrank and transformed from solid tumors into harmless cysts.

12 years later, she remains healthy and cancer-free—a living testament to faith, perseverance, and the power of innovation.

Cancer Survivor’s Note: “10 Years of ‘Friendship’ with Cancer (with ECCT)” Read More »

First Case of Stage 4 Ovarian Cancer Overcomes 11 Years Cancer-Free with ECCT Without Chemotherapy

Leave a Comment / Ovarian Cancer /

Diagnosed in 2012 with advanced-stage ovarian cancer that had spread to her bones, Mrs. Ida faced a near-impossible prognosis. Surgery was deemed too risky, and even with chemotherapy, doctors warned that the cancer would likely return. Determined to survive, she sought help from Dr. Warsito in Tangerang and began using the ECCT device designed specifically for her case.

Over the next few months, her condition changed dramatically—the once-solid tumor softened and turned fluid-filled, just as predicted. By early 2013, surgery became possible, and doctors successfully removed five large and small sacs of cancer tissue weighing about 5 kilograms. Continuing ECCT afterward, Mrs. Ida made a full recovery and showed no recurrence for years.

Now, more than 11 years later, she remains healthy and cancer-free—a remarkable story of perseverance, innovation, and faith against the odds.

First Case of Stage 4 Ovarian Cancer Overcomes 11 Years Cancer-Free with ECCT Without Chemotherapy Read More »

The First and Longest ECCT User for Lung Cancer Surpasses 12 Years, Following the Advice of the First Doctor to Accept ECCT

Leave a Comment / Adenocarcinoma, Lung Cancer /

Diagnosed with advanced-stage lung cancer in 2011, Mr. Abdulmalik faced grim odds—most patients in his condition survive less than five years. When conventional options offered little hope, his doctor, the first to accept ECCT, suggested he try the new therapy. Mr. Abdulmalik agreed, becoming the first person to use ECCT for lung cancer.

Within a month, his coughing blood subsided, and CT scans showed the tumor had shrunk by half. Over the following years, his condition steadily improved—breathing became normal, and by the third year, only scar tissue remained where the tumor once was.

Now, more than ten years later, Mr. Abdulmalik remains strong, active, and cancer-free—living proof of how determination and innovation can defy even the deadliest odds.

The First and Longest ECCT User for Lung Cancer Surpasses 12 Years, Following the Advice of the First Doctor to Accept ECCT Read More »